Dexamethasone Sodium Phosphate

規格

2392-39-4CAS番号

219-243-0EC番号

disodium;[2-[(8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] phosphateIUPAC名

C22H28FNa2O8P化学式

516.4 g/mol分子量

DEXAMETHASONE SODIUM PHOSPHATE; 2392-39-4; Dexamethasone 21-phosphate disodium salt; Dalalone; Dexadreson; Megacort; Soldesam; Dexamethasone disodium phosphate; Decadron phosphate; Dexabene; Ak-Dex; Dexair; Sodium dexamethasone phosphate; Dexacen-4; DTXSID3047429; MEPHAMESONE; SOLUDECADRON; TOTOCORTIN; TLC399; SOLUPEN N; TLC-399; AI9376Y64P; NSC-756722; CHEBI:4462; DTXCID1027429; Pregna-1,4-diene-3,20-dione, 9-fluoro-11,17-dihydroxy-16-methyl-21-(phosphonooxy)-, disodium salt, (11beta,16alpha)-; Cebedex; Dexacen; Ludaxine; Ropidex; Topidex; Viadox; Dexamethasone SP; Dekasol LA; Dexium-SP; Dex-A-Vet Injection; DMT SUIK; ReadySharp Dexamethasone; RefChem:54956; dexamethasoni natrii phosphas; dexamethasonedisodium phosphate; Dexamethasone Sodium Phosphates; Dexamethasone Sodium Phosphate Inj.; dexamethasone phosphate disodium salt; DEXAMETHASONE SODIUM PHOSPHATE PRESERVATIVE FREE; Dexamethasone Sodium Phosphate, Bupivacaine Hydrochloride; Dexamethasone Sodium Phosphate, Ropivacaine Hydrochloride, Povidine Iodine; Decaject; Prodex; Solurex; 55203-24-2; Orgadrone; Dexamethasone phosphate disodium; Dexamethasone 21-(disodium phosphate); C22H28FNa2O8P; 9-Fluoro-11beta,17,21-trihydroxy-16alpha-methylpregna-1,4-diene-3,20-dione 21-(dihydrogen phosphate) disodium salt; disodium;[2-[(8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] phosphate; Dexagro; Spersadox; Decdan; Solu-Decadron; Maxidex Ointment; MFCD00079105; Hexadrol Injectable; sodium 2-((8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl phosphate; Colvasone; Dexagel; Onadron; Baldex; Dexaject SP; disodium 9-fluoro-11beta,17-dihydroxy-16alpha-methyl-3,20-dioxopregna-1,4-dien-21-yl phosphate; CAS-2392-39-4; Disodium dexamethasone phosphate; 2392-39-4 (disodium); 21-Disodium phosphate dexamethasone; EINECS 219-243-0; Dexamethasone-21-phosphate disodium salt; UNII-AI9376Y64P; NCGC00094644-01; Dalalone (TN); Dexamethasone sodium phosphate [USP:BAN:JAN]; SCHEMBL7778; Dexamethasone phosphate sodium; MSK10004Na; Dexadreson; Dexagel; Dexagro; Dexamethasone 21-(disodium phosphate); orb1300745; orb1310142; CHEMBL2021430; Dexamethasone sodium phosphate RS; Dexamethasone sodium phosphate CRS; Dexamethasone 21-phosphate disodium; Tox21_113181; Tox21_302586; s4028; T0947L; AKOS015896357; AKOS015951212; CCG-269820; FD31952; KS-1150; NSC 756722; NCGC00256783-01; AC-17992; Dexamethasone sodium phosphate (JAN/USP); disodium (1R,2S,10S,11S,13R,14R,15S,17S)-1-fluoro-14,17-dihydroxy-2,13,15-trimethyl-14-[2-(phosphonatooxy)acetyl]tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-3,6-dien-5-one; Pregna-1,4-diene-3,20-dione, 9-fluoro-11,17-dihydroxy-16-methyl-21-(phosphonooxy)-, disodium salt, (11.beta.,16.alpha.)-; Pregna-1,4-diene-3,20-dione, 9-fluoro-11-beta,17,21-trihydroxy-16-alpha-methyl-, 21-(dihydrogen phosphate) disodium salt; DEXAMETHASONE PHOSPHATE (AS SODIUM); DEXAMETHASONE SODIUM PHOSPHATE [JAN]; NS00083368; T6465; DEXAMETHASONE SODIUM PHOSPHATE [MART.]; DEXAMETHASONE SODIUM PHOSPHATE [VANDF]; EN300-52795; C08175; D00975; DEXAMETHASONE SODIUM PHOSPHATE [USP-RS]; DEXAMETHASONE SODIUM PHOSPHATE [WHO-DD]; DEXAMETHASONE SODIUM PHOSPHATE [WHO-IP]; Dexamethasone 21-phosphate disodium salt, >=98%; DEXAMETHASONE SODIUM PHOSPHATE [GREEN BOOK]; F358382; DEXAMETHASONE SODIUM PHOSPHATE [EP MONOGRAPH]; DEXAMETHASONE SODIUM PHOSPHATE [ORANGE BOOK]; DEXAMETHASONE SODIUM PHOSPHATE [USP IMPURITY]; DEXAMETHASONI NATRII PHOSPHAS [WHO-IP LATIN]; DEXAMETHASONE 21-PHOSPHATE DISODIUM SALT [MI]; DEXAMETHASONE SODIUM PHOSPHATE [USP MONOGRAPH]; Q27106391; Dexamethasone sodium phosphate for peak identification CRS; NEODECADRON COMPONENT DEXAMETHASONE SODIUM PHOSPHATE; 9-Fluoro-11,17-dihydroxy-16-methyl-21-(phosphonooxy)pregna-1,4-diene-3,20-dione disodium; Dexamethasone sodium phosphate, British Pharmacopoeia (BP) Reference Standard; Dexamethasone sodium phosphate, European Pharmacopoeia (EP) Reference Standard; Dexamethasone sodium phosphate, United States Pharmacopeia (USP) Reference Standard; Dexamethasone sodium phosphate for peak identification, European Pharmacopoeia (EP) Reference Standard; Dexamethasone Sodium Phosphate, Pharmaceutical Secondary Standard; Certified Reference Material; disodium (1R,2R,3aS,3bS,9aS,9bR,10S,11aS)-9b-fluoro-1,10-dihydroxy-2,9a,11a-trimethyl-1-[2-(phosphonatooxy)acetyl]-1H,2H,3H,3aH,3bH,4H,5H,7H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-one; disodium;[2-[(8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] phosphate; Pregna-1,4-diene-3,20-dione, 9-fluoro-11,17-dihydroxy-16-methyl-21-(phosphonooxy)-, sodium salt (1:2), (11beta,16alpha)-別名